<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19
Image Overlay - Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19

Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19

Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19

Vanguard Clinical Research has begun conducting trials an oral medication to relieve symptoms for people with a mild to moderate infection. “The research has been approved for 100 patients. Those are people who either think they have COVID-19, for which they’ll be tested, or they may have a common cold,” said Dr. Alan Tannenbaum, medical director of the clinical research team at Vanguard Clinical Research. In addition to helping clinical trials at facilities, Yourway is helping to lead the charge toward a more patient-centric supply chain by offering direct-to-patient services.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?